Tag Archives: GSK Nigeria

GSK Nigeria shareholders vote to sell beverage business to Suntory

Ribena and Lucozade brands

GlaxoSmithKline Consumer Nigeria Plc (“GSK Consumer Nigeria”) said on Monday that shareholders of the company have approved the sale of its beverage unit to Suntory Beverage & Food Nigeria Limited.

GSK Nigeria dispels rumours of pending lay-offs after sale of beverage business

GlaxoSmithKline Consumer Nigeria Plc (GSK Nigeria) has put to rest fears of planned lay-offs post sale of its beverage business to Suntory.

Speaking to journalists in Lagos, GSK’s company Secretary, Mr. Uchenna Uwechia, said that the company’s Board of Directors has accepted Suntory Beverage & Food Limited offer to buy its beverage bottling and distribution business.

He noted that the Nigerian Stock Exchange (NSE) has been informed of its proposed plan to sell its beverage business as part of a post listing requirement of the exchange.

GSK Nigeria agrees to sell beverage unit to Suntory

GlaxoSmithKline Consumer Nigeria Plc (“GSK Nigeria”) said on Wednesday, it has accepted and is recommending to its shareholders, a binding offer from Suntory Beverage & Food Nigeria Ltd, a subsidiary of Suntory Beverage and Food Limited (“SBF”) of Japan, for the sale of its beverage unit, which includes bottling and distribution of Ribena, Lucozade and part of its Agbara plant.

GSK Consumer Nigeria posts 37% profit decline in the latest quarter

GlaxoSmithKline Consumer Nigeria Plc, the company behind beverage brands Lucozade and Ribena, among others, said on Thursday that its net income for the period January – March 31 2016 declined 37% to N188m, from N297m in the same quarter a year earlier.

GSK Nigeria in negotiations with Suntory to sell beverage business

Ribena and Lucozade brands

GSK Consumer Nigeria Plc, maker of Ribena and Lucozade brands has confirmed that it has received a non-binding offer from Suntory Beverage & Food Limited (SBF) for their beverage business consisting of the bottling and distribution of Ribena, Lucozade and part of their Agbara manufacturing plant.

GSK Nigeria posts higher results; shareholders applaud bonus dividend payout

GlaxoSmithkline Consumer Nigeria plc (GSK Nigeria) has announced a strong growth in its audited results for the year ended 31 December 2014, even as it approved bonus shares for its shareholders.

The company also declared a N717.5 million dividend for its shareholders for the year ended December 2014.

Speaking at the 44th Annual General Meeting (AGM) held in Lagos, Edmund Onuzo, Chairman GSK Nigeria Board of Directors stated that although the year 2014 was challenging, the company remains committed in ensuring shareholders get the best returns on their investments.